Stefan Rubner - Interview RGCC gathering 2023

Watch an interview with Stefan Rubner, Head of the Laboratory at RGCC's Research and Development Labs in Haale (Saale), Germany. Stefan takes you behind the scenes of RGCC's dynamic research environment, where diverse bioscientific areas work collectively to drive cancer research, from target identification to validation. What sets RGCC apart is the integration of these areas, creating a comprehensive approach to fighting cancer.
RGCC's research initiatives include both common and rare types of cancer.
Having joined RGCC nearly four years ago, Stefan reflects on the growth of the lab from its inception to a team of 12, including 11 scientists. The team operates with a focus on classical drugs like small molecules, peptides, and antibodies, as well as the exploration of advanced therapies like ATMPs (Advanced Therapy Medicinal Products).
Gain insights into the collaborative, innovative, and impactful work at RGCC's laboratories.
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou, who believes that the key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.
Individualized treatment for cancer is the focus behind RGCC’s testing protocols and advanced therapy options. Our slate of tests analyzes the state of a person’s cancer by looking at the cellular and genetic makeup of each patient. Our test results give you information that acts as a blueprint for what treatment protocols are likely to show the most efficacy for your specific biology.
Learn more about RGCC at
rgcc-internati...
myrgcc.com/
Follow us on social media to find out the latest news and updates from our experts.
Facebook:
/ rgcc.international
www.facebook.c...
Instagram:
/ research_genetic_cance...
/ rgcc_north_america
LinkedIn: / r-g-c-c-international-...